HomeGUD • TSE
Follow
Knight Therapeutics Inc
Previous close
$5.76
Day range
$5.75 - $5.76
Year range
$4.35 - $5.95
Market cap
580.30M CAD
Avg Volume
82.43K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 74.20M | -9.13% |
Operating expense | 34.30M | -25.49% |
Net income | -24.33M | -60.17% |
Net profit margin | -32.79 | -76.29% |
Earnings per share | -0.15 | — |
EBITDA | 7.87M | 21.74% |
Effective tax rate | 6.98% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 169.87M | -8.48% |
Total assets | 945.49M | -10.37% |
Total liabilities | 198.62M | -13.26% |
Total equity | 746.87M | — |
Shares outstanding | 101.17M | — |
Price to book | 0.78 | — |
Return on assets | -0.02% | — |
Return on capital | -0.02% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -24.33M | -60.17% |
Cash from operations | 17.94M | 170.31% |
Cash from investing | -1.90M | 97.08% |
Cash from financing | -35.70M | -227.62% |
Net change in cash | -18.66M | 38.11% |
Free cash flow | 60.62M | 888.67% |
About
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Founded
2014
Headquarters
Website
Employees
725
